Which term describes FDA-approved indications listed on labeling based on trial evidence?

• A. Labeled Indications
• B. Orphan Drugs
• C. Post-Market Surveillance
• D. Expedited Approval

Answer: (A)

The main idea is that the indications listed on a drug’s FDA-approved labeling are the uses that have been demonstrated in trials and officially approved. These official and trial-backed uses are called labeled indications. They guide how the drug is prescribed, including dosing and patient populations, and they distinguish approved uses from off-label uses (which aren’t on the label but may be used in practice).

Orphan Drugs refer to medicines designated for rare diseases, with incentives for development, not to labeling content. Post-Market Surveillance involves monitoring safety after a drug is approved, not the specific indications. Expedited Approval refers to faster pathways to approval, not the content of the labeling itself.